{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:53:23Z","timestamp":1784829203699,"version":"3.55.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.healun.2022.09.021","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T19:07:40Z","timestamp":1665256060000},"page":"40-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lung transplantation for lymphangioleiomyomatosis"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4157-5500","authenticated-orcid":false,"given":"Krishnan","family":"Warrior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9723-510X","authenticated-orcid":false,"given":"Daniel F.","family":"Dilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2022.09.021_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","author":"McCarthy","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-199909000-00004","article-title":"Pulmonary lymphangioleiomyomatosis: a study of 69 patients","volume":"78","author":"Urban","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.healun.2022.09.021_bib0003","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.200610-1408CR","article-title":"Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex","volume":"176","author":"Schiavina","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0004","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1164\/ajrccm.162.2.9911006","article-title":"Pulmonary Lymphangioleiomyomatosis in a Man","volume":"162","author":"Aubry","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4065\/75.6.591","article-title":"High frequency of pulmonary lymphangioeiomyomatosis in women with tuberous sclerosis complex","volume":"75","author":"Costello","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.healun.2022.09.021_bib0006","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm.164.4.2101154","article-title":"Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis Complex","volume":"164","author":"Moss","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0007","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.healun.2022.09.021_bib0008","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2022.09.021_bib0009","first-page":"348","article-title":"Pulmonary lymphangiomyomatosis: a review","volume":"79","author":"Corrin","year":"1975","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2022.09.021_bib0010","first-page":"977","article-title":"Lymphangioleiomyomatosis: physiologic-pathologic-radiologic correlations","volume":"116","author":"Carrington","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.healun.2022.09.021_bib0011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","article-title":"Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features","volume":"67","author":"Ferrans","year":"2000","journal-title":"J Nippon Med School"},{"key":"10.1016\/j.healun.2022.09.021_bib0012","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1164\/rccm.201205-0848OE","article-title":"Lymphangioleiomyomatosis - Calling it what it is: a low-grade, destructive, metastasizing neoplasm","volume":"186","author":"McCormack","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0013","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0014","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM199011013231807","article-title":"Lymphangioleiomyomatosis. Clinical course in 32 patients","volume":"323","author":"Taylor","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00088314","article-title":"Severity and outcome of cystic lung disease in women with tuberous sclerosis complex","volume":"45","author":"Taveira-Da Silva","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.09.021_bib0016","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0017","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American thoracic society\/Japanese respiratory society clinical practice guidelines: Lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0018","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0019","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.healun.2022.09.021_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.healun.2022.09.021_bib0021","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","article-title":"Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone","volume":"126","author":"Taveira-DaSilva","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.09.021_bib0022","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart\u2013lung transplantation Report\u20142019; Focus theme: donor and recipient size match","volume":"38","author":"Chambers","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0023","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","article-title":"Insulin activation of Rheb, a mediator of mTOR:S6K:4E-BP signaling, is inhibited by TSC1 and 2","volume":"11","author":"Garami","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.healun.2022.09.021_bib0024","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a Third Subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.healun.2022.09.021_bib0025","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"Benvenuto","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.healun.2022.09.021_bib0026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase:akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.healun.2022.09.021_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.healun.2022.09.021_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/20734735.0007-2020","article-title":"Lymphangioleiomyomatosis: a clinical review","volume":"16","author":"O'mahony","year":"2020","journal-title":"Breathe"},{"key":"10.1016\/j.healun.2022.09.021_bib0029","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.healun.2022.09.021_bib0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","article-title":"mTORC1 signaling and the metabolic control of cell growth","volume":"45","author":"Ben-Sahra","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.healun.2022.09.021_bib0031","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 Maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.healun.2022.09.021_bib0032","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/onc.2015.179","article-title":"Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP","volume":"35","author":"Ricoult","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.healun.2022.09.021_bib0033","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2014.164","article-title":"Tee AR. mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3","volume":"34","author":"Dodd","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.healun.2022.09.021_bib0034","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.chest.2017.07.027","article-title":"The 10,000-Piece Puzzle of Lymphangioleiomyomatosis","volume":"153","author":"Dilling","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.09.021_bib0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.chest.2017.05.018","article-title":"CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis","volume":"153","author":"Glasgow","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.09.021_bib0036","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1165\/rcmb.2005-0300OC","article-title":"Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: role for tumor suppressor TSC2","volume":"34","author":"Goncharova","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.healun.2022.09.021_bib0037","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1165\/ajrcmb.21.3.3693","article-title":"Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis","volume":"21","author":"Matsumoto","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.healun.2022.09.021_bib0038","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2353\/ajpath.2009.090525","article-title":"Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells","volume":"175","author":"Klarquist","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2022.09.021_bib0039","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201912-2445OC","article-title":"Single-cell transcriptomic analysis identifies a unique pulmonary lymphangioleiomyomatosis cell","volume":"202","author":"Guo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0040","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/rcmb.2018-0123OC","article-title":"Immune checkpoint ligand PD-L1 is upregulated in pulmonary lymphangioleiomyomatosis","volume":"59","author":"Maisel","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.healun.2022.09.021_bib0041","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98674","article-title":"TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1\/anti-CTLA-4 immunotherapy","volume":"3","author":"Liu","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2022.09.021_bib0042","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87270","article-title":"NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline","volume":"1","author":"Osterburg","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2022.09.021_bib0043","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis - A wolf in sheep's clothing","volume":"122","author":"Henske","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2022.09.021_bib0044","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.1309110110","article-title":"Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis","volume":"110","author":"Gu","year":"2013","journal-title":"Proc Nat Sci Acad USA"},{"key":"10.1016\/j.healun.2022.09.021_bib0045","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.healun.2022.09.021_bib0046","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-13-34","article-title":"Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis","volume":"13","author":"Chang","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.healun.2022.09.021_bib0047","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2004.023283","article-title":"Survival and disease progression in UK patients with lymphangioleiomyomatosis","volume":"59","author":"Johnson","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2022.09.021_bib0048","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1513\/AnnalsATS.201606-459OC","article-title":"Chest computed tomographic image screening for cystic lung diseases in patients with spontaneous pneumothorax is cost effective","volume":"14","author":"Gupta","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.healun.2022.09.021_bib0049","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1164\/rccm.201709-1965ST","article-title":"Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management an Official American thoracic society\/Japanese respiratory society clinical practice guideline","volume":"196","author":"Gupta","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0050","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00570-2015","article-title":"Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases","volume":"46","author":"Gupta","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.09.021_bib0051","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.09.021_bib0052","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","article-title":"Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis","volume":"52","author":"Zhe","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.healun.2022.09.021_bib0053","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.161.3.9904009","article-title":"Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy an immunohistochemical study","volume":"161","author":"Matsui","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0054","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0055","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/pbc.25573","article-title":"Dose-level response rates of mtor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)","volume":"62","author":"Weidman","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.healun.2022.09.021_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.resinv.2015.11.003","article-title":"Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: an analysis of the Japanese National Research Project on Intractable Diseases database","volume":"54","author":"Hayashida","year":"2016","journal-title":"Respir Investig"},{"key":"10.1016\/j.healun.2022.09.021_bib0057","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","article-title":"The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis","volume":"155","author":"Gupta","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.09.021_bib0058","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02066-2018","article-title":"Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis","volume":"53","author":"Gupta","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.09.021_bib0059","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/ajrccm.160.2.9901027","article-title":"Decline in lung function in lymphangioleiomyomatosis relation to menopause and progesterone treatment","volume":"160","author":"Johnson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0060","doi-asserted-by":"crossref","DOI":"10.1007\/s00408-012-9419-3","article-title":"Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry","volume":"191","author":"Oprescu","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.healun.2022.09.021_bib0061","first-page":"168","article-title":"Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis","author":"di Marco","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0062","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1843.2007.01101.x","article-title":"Respiratory Failure Research Group of the Japanese Ministry of Health L and W. The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors","volume":"12","author":"Hayashida","year":"2007","journal-title":"respirol"},{"key":"10.1016\/j.healun.2022.09.021_bib0063","doi-asserted-by":"crossref","DOI":"10.1378\/chest.129.5.1267","article-title":"Patient Perspectives on Management of Pneumothorax in Lymphangioleiomyomatosis","volume":"129","author":"Young","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.09.021_bib0064","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.129.5.1274","article-title":"Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications","volume":"129","author":"Almoosa","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.09.021_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146749","article-title":"Lung transplantation for lymphangioleiomyomatosis in Japan","volume":"11","author":"Ando","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2022.09.021_bib0066","unstructured":"OPTN Data. Organ Procurement and Transplantation Network website. Available at: https:\/\/optn.transplant.hrsa.gov\/data\/. Accessed May 1, 2022."},{"key":"10.1016\/j.healun.2022.09.021_bib0067","article-title":"Combined heart-and-lung transplantation for lymphangioleiomyomatosis","volume":"1","author":"Estenne","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2022.09.021_bib0068","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199610243351704","article-title":"Lung transplantation for lymphangioleiomyomatosis","volume":"335","author":"Boehler","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0069","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1053-2498(03)00195-5","article-title":"Lung transplantation for lymphangioleiomyomatosis","volume":"23","author":"Pechet","year":"2004","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0070","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.healun.2004.09.013","article-title":"The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis","volume":"24","author":"Kpodonu","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0071","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e31817c15df","article-title":"Lung transplantation for lymphangioleiomyomatosis: the French experience","volume":"86","author":"Reynaud-Gaubert","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.09.021_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2008.09.014","article-title":"Lung transplantation for lymphangioleiomyomatosis: the European experience","volume":"28","author":"Benden","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0073","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.transproceed.2010.12.051","article-title":"Lung transplantation for lymphangioleiomyomatosis: Single-center Brazilian experience with no chylothorax","volume":"43","author":"Machuca","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.09.021_bib0074","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.transproceed.2015.04.103","article-title":"Lung transplantation for lymphangioleiomyomatosis in a single japanese institute, with a focus on late-onset complications","volume":"47","author":"Nakagiri","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.09.021_bib0075","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.rmed.2015.08.014","article-title":"Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis","volume":"109","author":"Ussavarungsi","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0076","doi-asserted-by":"crossref","DOI":"10.1007\/s00408-017-0045-y","article-title":"Experience of lung transplantation in patients with lymphangioleiomyomatosis at a brazilian reference centre","volume":"195","author":"Baldi","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.healun.2022.09.021_bib0077","article-title":"Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan","volume":"48","author":"Oishi","year":"2018","journal-title":"Surg Today"},{"key":"10.1016\/j.healun.2022.09.021_bib0078","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.healun.2019.06.015","article-title":"Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis","volume":"38","author":"Khawar","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0079","doi-asserted-by":"crossref","DOI":"10.1177\/1526924819835815","article-title":"Long-term results of bilateral lung transplantation in patients with end-stage pulmonary lymphangioleiomyomatosis","volume":"29","author":"Salman","year":"2019","journal-title":"Prog Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/crj.13108","article-title":"Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation\u2014long-term follow-up of a Japanese center","volume":"14","author":"Kurosaki","year":"2020","journal-title":"Clinical Respiratory Journal"},{"key":"10.1016\/j.healun.2022.09.021_bib0081","article-title":"A retrospective study of lung transplantation in patients with lymphangioleiomyomatosis: challenges and outcomes","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.healun.2022.09.021_bib0082","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1038\/s41598-022-12314-1","article-title":"Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea","volume":"12","author":"Chang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.healun.2022.09.021_bib0083","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.healun.2022.09.021_bib0084","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/ajt.16991","article-title":"OPTN\/SRTR 2020 Annual Data Report: lung","volume":"22","author":"Valapour","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0964-6","article-title":"Air travel and incidence of pneumothorax in lymphangioleiomyomatosis","volume":"13","author":"Gonano","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.healun.2022.09.021_bib0086","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014 - an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation","volume":"34","author":"Weill","year":"2015","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0087","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/17476348.2014.956728","article-title":"Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?","volume":"8","author":"El-Chemaly","year":"2014","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0088","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1053-2498(03)00309-7","article-title":"Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression","volume":"23","author":"Groetzner","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0089","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/01.TP.0000064083.02120.2C","article-title":"Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation","volume":"75","author":"King-Biggs","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.09.021_bib0090","unstructured":"Rapamune. Black box warning in package insert. in Wyeth Pharmaceuticals Inc PA, Philadelphia."},{"key":"10.1016\/j.healun.2022.09.021_bib0091","first-page":"195","article-title":"A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant","author":"Warrior","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0092","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1440-1843.2011.01955.x","article-title":"An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis","volume":"16","author":"Malouf","year":"2011","journal-title":"respirol"},{"key":"10.1016\/j.healun.2022.09.021_bib0093","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1016\/j.healun.2020.01.334","article-title":"Continuation of mTOR inhibition in LAM patients listed for lung transplant is safe","volume":"39","author":"Warrior","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0094","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-017-0626-0","article-title":"Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method","volume":"12","author":"Freitas","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.healun.2022.09.021_bib0095","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1378\/chest.07-1205","article-title":"Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study","volume":"132","author":"Taveira-DaSilva","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.09.021_bib0096","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1183\/13993003.01177-2015","article-title":"The 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress","volume":"46","author":"Lau","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.09.021_bib0097","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/09031936.00093111","article-title":"Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients","volume":"40","author":"Cottin","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.09.021_bib0098","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11684-018-0634-z","article-title":"Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients","volume":"13","author":"Wu","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0099","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1096\/fj.10-175018","article-title":"mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia","volume":"25","author":"Krymskaya","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.healun.2022.09.021_bib0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/2045-8932.83455","article-title":"Lung transplantation for pulmonary hypertension","volume":"1","author":"George","year":"2011","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2022.09.021_bib0101","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0003-4975(01)03081-8","article-title":"Lung transplantation for primary and secondary pulmonary hypertension","volume":"72","author":"v","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0102","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/15412555.2015.1043425","article-title":"Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation","volume":"13","author":"Hayes","year":"2016","journal-title":"COPD: Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1016\/j.healun.2022.09.021_bib0103","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.athoracsur.2018.04.060","article-title":"Single- versus double-lung transplantation in pulmonary fibrosis: impact of age and pulmonary hypertension","volume":"106","author":"Villavicencio","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s41030-020-00141-6","article-title":"Postoperative management of hyperinflated native lung in single-lung transplant recipients with chronic obstructive pulmonary disease: a review article","volume":"7","author":"Shehata","year":"2021","journal-title":"Pulm Ther"},{"key":"10.1016\/j.healun.2022.09.021_bib0105","first-page":"2137","article-title":"Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations","volume":"10","author":"Lane","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.healun.2022.09.021_bib0106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5761\/atcs.cr.13-00133","article-title":"Right native lung pneumonectomy due to over inflation three years after left single lung transplantation for pulmonary lymphangioleiomyomatosis","volume":"20","author":"Liu","year":"2014","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0107","first-page":"E114","article-title":"Fatal hemoptysis due to endobronchial aspergilloma in the hyperinflated native lung after single-lung transplantation for lymphangioleiomyomatosis: a case report","volume":"65","author":"Yoshizaki","year":"2020","journal-title":"Kobe J Med Sci"},{"key":"10.1016\/j.healun.2022.09.021_bib0108","doi-asserted-by":"crossref","DOI":"10.4065\/80.7.867","article-title":"Etiology of chylothorax in 203 patients","volume":"80","author":"Doerr","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.healun.2022.09.021_bib0109","doi-asserted-by":"crossref","DOI":"10.1097\/MAJ.0b013e3181cdcd6c","article-title":"Medical and surgical management of chylothorax and associated outcomes","volume":"339","author":"Maldonado","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.healun.2022.09.021_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5223(96)70152-6","article-title":"Postoperative chylothorax","volume":"112","author":"Cerfolio","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0111","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.athoracsur.2014.03.003","article-title":"The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection","volume":"98","author":"Bryant","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0112","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.5190","article-title":"Incidence, management, and outcomes of chylothorax after lung transplantation: a single-center experience","author":"Jacob","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.healun.2022.09.021_bib0113","doi-asserted-by":"crossref","DOI":"10.1055\/s-2001-18797","volume":"22","author":"Doerr","year":"2001","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0114","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/0884533608323424","article-title":"Chyle leaks: consensus on management?","volume":"23","author":"Smoke","year":"2008","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.healun.2022.09.021_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcts.2007.04.024","article-title":"Aetiology and management of chylothorax in adults","volume":"32","author":"Nair","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcts.2007.11.028","article-title":"A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery","volume":"33","author":"Boffa","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0117","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thorsurg.2014.09.005","article-title":"Pleural space complications associated with lung transplantation","volume":"25","author":"Arndt","year":"2015","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.healun.2022.09.021_bib0118","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.resinv.2013.03.002","article-title":"Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis","volume":"51","author":"Ando","year":"2013","journal-title":"Respir Investig"},{"key":"10.1016\/j.healun.2022.09.021_bib0120","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1016\/j.healun.2021.01.945","article-title":"Efficacy and tolerability of sirolimus in lymphangioleiomyomatosis patients after lung transplantation: single-center experience in Japan","volume":"40","author":"Suzuki","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0121","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.1016\/j.healun.2018.01.1186","article-title":"Experience of Using mTOR Inhibitor in Lung Transplant at Recipients With Lymphangioleiomyomatosis","volume":"37","author":"Kurosaki","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0122","article-title":"Refractory chylous effusions in lymphangioleiomyomatosis patient post lung transplant","volume":"8","author":"Jacob","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.healun.2022.09.021_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2007.07.008","article-title":"Chylothoraces after lung transplantation for lymphangioleiomyomatosis: review of the literature and utilization of a pleurovenous shunt","volume":"26","author":"Fremont","year":"2007","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0124","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.athoracsur.2020.06.052","article-title":"Natural history of pleural complications after lung transplantation","volume":"111","author":"Tang","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0125","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S1053-2498(02)01230-5","article-title":"Acute and chronic pleural complications in lung transplantation","volume":"22","author":"Ferrer","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.021_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5223(05)80005-4","article-title":"Pleural complications in lung transplant recipients","volume":"110","author":"Herridge","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0127","doi-asserted-by":"crossref","DOI":"10.1055\/s-2004-832714","article-title":"Role of flexible bronchoscopy in lung transplantation","volume":"25","author":"Chhajed","year":"2004","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0128","doi-asserted-by":"crossref","DOI":"10.1111\/j.1432-2277.2011.01392.x","article-title":"An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients","volume":"25","author":"Smith","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2022.09.021_bib0129","first-page":"555","article-title":"Thoracoscopic treatment of recurrent contralateral pneumothorax after single lung transplantation","volume":"13","author":"Venuta","year":"1994","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/0003-4975(94)90231-3","article-title":"Videothoracoscopic pleurectomy after contralateral single-lung transplantation","volume":"57","author":"Waller","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0131","first-page":"714","article-title":"Lymphangioleiomyomatosis: recurrence after lung transplantation","volume":"13","author":"Nine","year":"1994","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0132","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2006.08.145","article-title":"Recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation","volume":"38","author":"Chen","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.09.021_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2008.07.107","article-title":"Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation","volume":"87","author":"Chen","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2022.09.021_bib0134","doi-asserted-by":"crossref","DOI":"10.1053\/hupa.2003.50","article-title":"Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis","volume":"34","author":"Bittmann","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.healun.2022.09.021_bib0135","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.09.021_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2008.05.012","article-title":"Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation","volume":"27","author":"Sugimoto","year":"2008","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0137","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol Dialysis Transpl"},{"key":"10.1016\/j.healun.2022.09.021_bib0138","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.carj.2018.01.002","article-title":"What are the indications for prophylactic embolization of renal angiomyolipomas? A review of the current evidence in the literature","volume":"69","author":"Ryan","year":"2018","journal-title":"Can Assoc Radiol J"},{"key":"10.1016\/j.healun.2022.09.021_bib0139","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jvir.2017.11.003","article-title":"Superselective Transcatheter Arterial Embolization for Large Unruptured Renal Angiomyolipoma in Lymphangioleiomyomatosis","volume":"29","author":"Kato","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.healun.2022.09.021_bib0140","first-page":"75","article-title":"Highly effective sirolimus therapy for abdominal lymphangioleiomyoma","author":"Lecuelle","year":"2019","journal-title":"Respir Med Res"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822021659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822021659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:47:08Z","timestamp":1760950028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249822021659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1053249822021659"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2022.09.021","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung transplantation for lymphangioleiomyomatosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2022.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}